HSPA1A and cancer: Additionally, combining HSP70 inhibitors, such as Apoptozole, VER-155008, PES, quercetin, or ADD70, with HSP90 inhibitors have also shown great therapeutic potential in numerous cancers, including muscle invasive bladder cancer, anaplastic thyroid carcinoma, melanoma, colorectal cancer, and acute myeloid leukemia [134,162,163,164,165,166,167].